Alzheimer's is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn't easy.
L’expertise universitaire, l’exigence journalistique
Articles sur 23andMe
Ensemble des articles
Data and privacy issues are tangled up in the DNA reports consumers get from big genetic testing companies – and the third-party sites they turn to in order to glean more from their raw DNA.
More people are sending off saliva samples to find out about their genetic roots. But the raw DNA results go way beyond genealogical data – and could deliver unintended consequences.
A genetics testing company recently won approval from the FDA to market a test that can identify a breast cancer gene mutation. But what are women supposed to do with that information? There's risk involved.
The market for personal genome services is facing a reality check. While the most prominent and innovative company 23andMe has flourished so far, in the past few years many of its competitors have gone…
Genetic testing is a powerful tool. Two years ago, with the help of my colleagues, it was this tool that helped us identify a new disease. The disease, called Ogden Syndrome, caused the death of a four-month…
Les contributeurs les plus fréquents
-
Assistant Professor in Human Genetics, Cold Spring Harbor Laboratory
-
Research Professor of Epidemiology, Emory University
-
Professor of Biology, Boise State University
-
Research Scientist in Biostatistics and PhD Candidate in Public Health Genetics, University of Washington
-
Associate Professor of Community Health Sciences, Boston University
-
Assistant Professor of Bioethics and Genomics, University of South Florida
